Name
Section
Date
Chapter 12 Financial Reporting Problem
Apple Inc.
2014
(a)
Net cash provided by operating activities (in millions)
(b)
(c)
(d)
(e)
(f)
713
2013
CONSOLIDATED STATEMENTS OF OPERATIONS
( In millions, except number of shares which are reflected in thousands and per share amounts)
Net sales
Years onded
September 27, September 28, September 29,
2014
2013
2012
$ 182,796 $ 170,910 $ 156,508
112,258 106,606 87,846
70,537 64,304
68,662
6,041
4,475
3,381
Cost of sales
Gross margin
Operating expenses: :
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Other income/(exponse), net
Income before provision for income taxes
Provision for income taxes
Net income
11,993
18,034
10,830
15.305
48.999
10,040
13,421
55,241
522
52,503
980
1,156
50,155
55,763
53,483
13,973
39,510
13.118
14,030
$
$
37,037
$
41.733
Earnings per share:
Basic
$
6.49
$
5.72
$
6.38
Diluted
$
6.45
$
5.68
$
6.31
Shares used in computing earnings per share:
Basic
Diluted
6,085,572
6,122,663
6,477,320
6,521,634
6,543,726
6,617,483
Cash dividends declared per common share
$
1.82
$
1.64
$
0.38
See accompanying Notes to Consolidated Financial Statements. .
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
In millions) )
Years ended
September 27, September 28, September 29,
2014
2013
2012
$ 39,510 $ 37,037 $ 41,733
(137)
(112)
(15)
1,390
522
(131)
149
(458)
(399)
Net Income
Other comprehensive income/loss):
Change in foreign currency translation, net of tax effects of $50, $35
and $13, respectively
$
Change in unrecognized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax benefit/(expense) of $(297).
$(351) and $73, respectively
Adjustment for net losses/gains) realized and included in net income,
net of tax expense/benefit) of $(36), $255 and $220, respectively
Total change in unrecognized gains/losses on derivative
instruments, net of tax
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax benefit/
(expense) of $(153), $458 and $(421), respectively
Adjustment for net losses/gains) realized and included in net income,
net of tax expense/benefit) of $71, $82 and $68, respectively
Total change in unrealized gains/losses on marketable securities,
net of tax
Total other comprehensive income/(loss)
Total comprehensive income
1,539
64
(530)
285
(791)
715
(134)
(131)
(114)
601
151
1.553
(922)
(970)
56
$
41,063
$
36,067
$
41,789
See accompanying Notes to Consolidated Financial Statements.
CONSOLIDATED STATEMENTS OF OPERATIONS
( In millions, except number of shares which are reflected in thousands and per share amounts)
Net sales
Years onded
September 27, September 28, September 29,
2014
2013
2012
$ 182,796 $ 170,910 $ 156,508
112,258 106,606 87,846
70,537 64,304
68,662
6,041
4,475
3,381
Cost of sales
Gross margin
Operating expenses: :
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Other income/(exponse), net
Income before provision for income taxes
Provision for income taxes
Net income
11,993
18,034
10,830
15.305
48.999
10,040
13,421
55,241
522
52,503
980
1,156
50,155
55,763
53,483
13,973
39,510
13.118
14,030
$
$
37,037
$
41.733
Earnings per share:
Basic
$
6.49
$
5.72
$
6.38
Diluted
$
6.45
$
5.68
$
6.31
Shares used in computing earnings per share:
Basic
Diluted
6,085,572
6,122,663
6,477,320
6,521,634
6,543,726
6,617,483
Cash dividends declared per common share
$
1.82
$
1.64
$
0.38
See accompanying Notes to Consolidated Financial Statements. .
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
In millions) )
Years ended
September 27, September 28, September 29,
2014
2013
2012
$ 39,510 $ 37,037 $ 41,733
(137)
(112)
(15)
1,390
522
(131)
149
(458)
(399)
Net Income
Other comprehensive income/loss):
Change in foreign currency translation, net of tax effects of $50, $35
and $13, respectively
$
Change in unrecognized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax benefit/(expense) of $(297).
$(351) and $73, respectively
Adjustment for net losses/gains) realized and included in net income,
net of tax expense/benefit) of $(36), $255 and $220, respectively
Total change in unrecognized gains/losses on derivative
instruments, net of tax
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax benefit/
(expense) of $(153), $458 and $(421), respectively
Adjustment for net losses/gains) realized and included in net income,
net of tax expense/benefit) of $71, $82 and $68, respectively
Total change in unrealized gains/losses on marketable securities,
net of tax
Total other comprehensive income/(loss)
Total comprehensive income
1,539
64
(530)
285
(791)
715
(134)
(131)
(114)
601
151
1.553
(922)
(970)
56
$
41,063
$
36,067
$
41,789
See accompanying Notes to Consolidated Financial Statements.
NSOLIDATED BALANCE SHEETS
(In millions, except number of shares which are reflected in thousands and par value)
September 27
2014
September 28.
2013
$
13,844
11,233
17,460
2,111
4,318
14,259
26,287
13,102
1,764
3,453
7,539
6.882
9,759
9,806
68,531
130,162
20,624
4,616
4,142
3,764
$ 231.839
73,286
106,215
16,597
1,577
4,179
5,146
$ 207.000
ASSETS:
Current assets:
Cash and cash equivalents
Short-term marketable securities
Accounts receivable, less allowances of $86 and $09, respectively
Inventories
Deferred tax assets
Vendor non-trade receivables
Other current assets
Total current assets
Long-term marketable securities
Property, plant and equipment, net
Goodwill
Acquired intangible assets, net
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY:
Current liabilities:
Accounts payable
Accrued expenses
Deferred revenue
Commercial paper
Total current liabilities
Deferred revenue-non-current
Long-term debt
Other non-current liabilities
Total liabilities
Commitments and contingencies
Shareholders' equity:
Common stock and additional paid-in capital, $0.00001 par value; 12,600,000 shares
authorized: 5,866,161 and 6,294,494 shares issued and outstanding, respectively
Retained earnings
Accumulated other comprehensive income/loss)
Total shareholders' equity
Total liabilities and shareholders' equity
$
30,196
$
22,367
18,453
13,856
7,435
0
8,491
6,308
63,448
3,031
28,987
43,658
2,625
16,960
20,208
24,826
120,292
83,451
19,764
23,313
87,152
1,082
104,256
(471)
123,549
$ 207,000
111,547
$ 231,839
See accompanying Notes to Consolidated Financial Statements.
ONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(In millions, except number of shares which are reflected in thousands)
Common Stock and
Additional Pald-in Capital
Sharos Amount
6,504,937 $ 13,331
0
Retained
Eamings
$ 62,841
41,733
0
Accumulated
Other
Total
Comprehensive Shareholders
Income/(LOSS) Equity
$ 443 $ 76,615
0 41,733
56
56
0
2,523)
0
1,740
O O
0
0
0
(2,523)
0
O
1,740
69,521
200
(762)
0
(562)
1,151
16,422
6,574,458
499
0
0
0
0
0
101,289
37,037
0
(10,676)
(22,950)
0
(970)
0
1,151
118,210
37,037
(970)
(10,676)
(22,950)
2,253
0
0
0
0
(328,837)
0
2,253
0
Balances as of September 24, 2011
Net income
Other comprehensive income/loss)
Dividends and dividend equivalents declared
Share-based compensation
Common stock issued, net of shares
withheld for employee taxes
Tax benefit from equity awards, including
transfer pricing adjustments
Balances as of September 29, 2012
Not income
Other comprehensive income/loss)
Dividends and dividend equivalents declared
Repurchase of common stock
Share-based compensation
Common stock issued, net of shares
withheld for employee taxes
Tax benefit from equity awards, including
transfer pricing adjustments
Balances as of September 28, 2013
Net income
Other comprehensive income/loss)
Dividends and dividend equivalents declared
Repurchase of common stock
Share-based compensation
Common stock issued, net of shares
withheld for employee taxes
Tax benefit from equity awards, including
transfer pricing adjustments
Balances as of September 27, 2014
48,873
(143)
(444)
0
(587)
0
1,232
19,764
(471)
6,294,494
0
0
0
0
1,553
Oo
104,256
39,510
0
(11,215)
(45,000)
0
1,232
123,549
39,510
1,553
(11,215)
(45,000)
2,863
0
0
(488,677)
0
0
0
2,863
0
60,344
(49)
(399)
0
(448)
0
735
0
735
5,866,161
$ 23,313
$ 87,152
$ 1,082
$111,547
See accompanying Notes to Consolidated Financial Statements.
Purchase answer to see full
attachment